Related Experiment Video
Updated: Oct 26, 2025
07:32
Biolistic Transformation of a Fluorescent Tagged Gene into the Opportunistic Fungal Pathogen Cryptococcus neoformans
Published on: March 19, 2015
10.2K
Cryptococcus neoformans CAP10 Gene Regulates the Immune Response in Mice
Liping Lin1, Shanshan Chen1, Junhui Zhang1
1Department of Clinical Laboratory, School of Medical Technology and Engineering, Fujian Medical University, 88 Jiaotong Road, Fuzhou, Fujian Province, 350004, PR China.
Journal De Mycologie Medicale
|July 26, 2021
Summary
Down-regulating the CAP10 gene in Cryptococcus neoformans infections reduced lung inflammation and fungal burden in mice. This suggests CAP10 is a potential therapeutic target for cryptococcosis.
Area of Science:
- Mycology
- Immunology
- Molecular Biology
Background:
- The capsule-associated protein 10 (CAP10) gene is crucial for polysaccharide capsule formation in Cryptococcus neoformans.
- CAP10 is closely linked to the virulence of C. neoformans, a significant human pathogen.
Purpose of the Study:
- To investigate the role of the CAP10 gene in pulmonary Cryptococcus neoformans infection.
- To evaluate the therapeutic potential of down-regulating CAP10 expression.
Main Methods:
- Designed shRNA expression plasmids to interfere with CAP10 gene synthesis.
- Infected mice via the respiratory tract and monitored lung tissue for infection development.
- Assessed pathological lesions, inflammatory cell infiltration, and fungal burden.
Main Results:
- Mice treated with cap10-shRNA showed alleviated pathological lesions and reduced inflammatory cell infiltration in pulmonary C. neoformans infection.
- A significantly lower fungal burden was observed in the cap10-shRNA group, indicating enhanced clearance.
- Down-regulation of CAP10 improved Th1/Th2 and Th17/Treg immune balance.
Conclusions:
- CAP10 gene expression is associated with the antifungal immune response in mice.
- CAP10 plays a regulatory role in the inflammatory response during cryptococcosis.
- The CAP10 gene represents a promising molecular therapeutic target for cryptococcosis treatment.
